Decision on Paid-in Capital Increase
네오이뮨텍
950220
Signal Score
Historical Avg Return (5d)
+0.38%
Data Coverage
100%n=2330
Risk-adjusted indicator based on 2330 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event: Paid-in Capital Increase
AI Analysis Summary
NeoImmuneTech, Inc. has announced a decision on a paid-in capital increase. While specific financial figures are not available, this type of event typically leads to share dilution, negatively impacting existing shareholder value. The purpose of the funds raised is unknown without further details, but it could be for R&D, operations, or debt repayment. Investors should monitor the issuance terms, including the number of new shares and pricing, for a full assessment of the dilution impact.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.